Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome.

Goyal, S D

Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome. [electronic resource] - Bone marrow transplantation Aug 2015 - 1057-62 p. digital

Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

1476-5365

10.1038/bmt.2015.82 doi


Adolescent
Adult
Aged
Allografts
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myeloid, Acute--mortality
Meningeal Neoplasms--mortality
Middle Aged
Neoplasms, Second Primary--mortality
Sarcoma, Myeloid--mortality
Skin Neoplasms--mortality